Moleac Pte Ltd - Company Review
Moleac Pte Ltd - Company ReviewSummary
Moleac Pte Ltd (Moleac) is a healthcare products provider that develops therapeutic products. The company conducts research on molecular biology, pharmacology and traditional medicines. Its products include NeuroAiD MLC 601 and NeuroAiD MLC 901, used for the treatment of traumatic brain injuries, stroke disabilities, and degenerative diseases. Moleac’s products helps patients to recover functional skills in the post stroke rehabilitation process. The company also provides natural treatment for post-stroke recovery. It develops drugs for the treatment of acute stroke, stroke prevention, Alzheimer’s disease, and central and peripheral nerve systems. The company markets its products through distributors located in different parts of the world. Moleac is headquartered in Singapore.
This comprehensive company report of Moleac Pte Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.